Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 11/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.52 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.52 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.52 |
| ▸ | OGT | O15294 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1519760 | 1.00 | P2RY2 (0.52) | P2RY2P2RY6P2RY4P2RY14OGT | |
| Pyruvate SCHEMBL11424485 | 0.97 | P2RY2 (0.50) | P2RY2P2RY6P2RY4P2RY14OGT | |
| SCHEMBL875379 | 0.94 | P2RY2 (0.53) | P2RY2P2RY6P2RY4P2RY14OGT | |
| SCHEMBL6421384 | 0.94 | P2RY2 (0.52) | P2RY2P2RY6P2RY4P2RY14OGT | |
| SCHEMBL15333769 | 0.94 | P2RY2 (0.53) | P2RY2P2RY6P2RY4P2RY14OGT | |
| SCHEMBL8373272 | 0.90 | P2RY2 (0.54) | P2RY2P2RY6P2RY4P2RY14OGT | |
| SCHEMBL2491234 | 0.90 | P2RY2 (0.54) | P2RY2P2RY6P2RY4P2RY14OGT | |
| Uridine_Diphosphate SCHEMBL404650 | 0.89 | P2RY6 (0.61) | P2RY2P2RY6P2RY4P2RY14OGT | |
| Uridine_Diphosphate SCHEMBL3508085 | 0.89 | P2RY6 (0.61) | P2RY2P2RY6P2RY4P2RY14OGT | |
| Uridine_Diphosphate SCHEMBL28093501 | 0.89 | P2RY6 (0.61) | P2RY2P2RY6P2RY4P2RY14OGT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767546-B2 | Enzymatic method for preparation of UDP-GlcNAc | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-09-26 | — | — | US | claimed |
| US-11739358-B2 | Enzymatic method for preparation of UDP-galactose | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-08-29 | — | — | US | claimed |
| EP-3874056-B1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC | MAX PLANCK GESELLSCHAFT (DE) | 2023-06-14 | — | — | EP | claimed |
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | Glycure LLC (US) | 2023-03-02 | — | — | US | claimed |
| US-20220380820-A1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-12-01 | — | — | US | claimed |
| EP-3874056-A1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-08 | — | — | EP | claimed |
| US-11060074-B2 | Self-regenerating hyaluronan polymer brushes | GEORGIA TECH RESEARCH CORPORATION (US) | 2021-07-13 | — | — | US | claimed |
| EP-3819382-A1 | ENZYMATIC METHOD FOR PREPARATION OF UDP-GLCNAC | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-05-12 | — | — | EP | claimed |
| US-20190276807-A1 | Self-Regenerating Hyaluronan Polymer Brushes | GEORGIA TECH RESEARCH CORPORATION | 2019-09-12 | — | — | US | claimed |
| US-20180194794-A1 | Activated N-Acetylated Sugars and Oligosaccharides | ZUCHEM INC (US) | 2018-07-12 | — | — | US | claimed |
| US-7005279-B1 | Process for producing carbohydrates using β 1,3-N-acetyl-glucosaminyltransferase | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2006-02-28 | — | — | US | claimed |
| WO-2005025556-A2 | ANTIBIOTIC CYCLOALKYLTETRAHYDROQUINOLINE DERIVATIVES | OSCIENT PHARMACEUTICALS (US) | 2005-03-24 | — | — | WO | claimed |
| US-20050019874-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-01-27 | — | — | US | claimed |
| US-6589762-B1 | Incubating test sample in culture of fungus containing the fluorochrome and observing cell growth; use in identification of potential fungicides and insecticides | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-08 | — | — | US | claimed |
| US-20020064836-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-05-30 | — | — | US | claimed |
| EP-1197556-A1 | USEFUL POLYPEPTIDE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-04-17 | — | — | EP | claimed |
| US-20020025560-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-02-28 | — | — | US | claimed |
| EP-0870841-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-10-14 | — | — | EP | claimed |
| US-5707846-A | DERIVED FROM HUMAN LUNG CANCER CELLS | SUNTORY LIMITED (JP) | 1998-01-13 | — | — | US | claimed |
| EP-0334962-A1 | METHOD FOR DIAGNOSIS OF HEPATIC CANCER OR HEPATOCIRRHOSIS | ORIENTAL YEAST CO., LTD. (JP) | 1989-10-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230060588-A1 | METHODS OF AMELIORATING AND/OR PREVENTING CORONAVIRUS-RELATED INFECTIONS | FUT5, FUT6, SIGLEC7 | P2RY2 4000/4885P2RY6 3215/4885P2RY4 3553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.